Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia

Overview of attention for article published in Acta Neuropathologica Communications, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 95 Dimensions

Readers on

mendeley: 143 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISORDER

Application WO-2023163187-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.